Asepsis Announces the Grant of Canada Patent Application CA2937327 for the Momenta-Dose™ – Force Actuated Injection. mikeJanuary 9, 2018 5:05 pmJanuary 9, 2018 Previous ArticleAsepsis Medical Announces the Notice of Patent Grant US 9775950 for the Vi-Syringe™ – Vision Impaired Syringe.Next ArticleAsepsis announces the USPTO Notice of Allowance for Patent Application No. 14/877,349 encompassing the prefilled and ready to fill, Diluent-2-Dose™ syringe.
